Impact of Genetic Polymorphisms on the Metabolic Pathway of Vitamin D and Survival in Non-Small Cell Lung Cancer

Vitamin D has been associated with risk, development, and progression of cancer. However, the genes involved in its metabolism are highly polymorphic, compromising its activity. The aim of this study is to evaluate the association between the gene polymorphisms involved in the metabolic pathway of v...

Full description

Bibliographic Details
Main Authors: Laura Elena Pineda Lancheros, Cristina Pérez Ramírez, Almudena Sánchez Martín, José María Gálvez Navas, Fernando Martínez Martínez, María del Carmen Ramírez Tortosa, Alberto Jiménez Morales
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/13/11/3783
_version_ 1797509029487968256
author Laura Elena Pineda Lancheros
Cristina Pérez Ramírez
Almudena Sánchez Martín
José María Gálvez Navas
Fernando Martínez Martínez
María del Carmen Ramírez Tortosa
Alberto Jiménez Morales
author_facet Laura Elena Pineda Lancheros
Cristina Pérez Ramírez
Almudena Sánchez Martín
José María Gálvez Navas
Fernando Martínez Martínez
María del Carmen Ramírez Tortosa
Alberto Jiménez Morales
author_sort Laura Elena Pineda Lancheros
collection DOAJ
description Vitamin D has been associated with risk, development, and progression of cancer. However, the genes involved in its metabolism are highly polymorphic, compromising its activity. The aim of this study is to evaluate the association between the gene polymorphisms involved in the metabolic pathway of vitamin D and survival in patients with non-small-cell lung cancer (NSCLC). The study was designed as an observational cohort which included 194 Caucasians patients from southern Spain with NSCLC. Real-time polymerase chain reaction was used to analyze the following polymorphisms: <i>CYP27B1</i> rs4646536, rs3782130, and rs10877012; <i>CYP24A1</i> rs6068816 and rs4809957; <i>GC</i> rs7041; <i>CYP2R1</i> rs10741657; <i>VDR</i> rs1544410 (BsmI), rs11568820 (Cdx-2), rs2228570 (FokI), rs7975232 (ApaI), and rs731236 (TaqI). Progression-free survival (PFS) and overall survival were assessed. Cox regression showed that rs4646536 was associated with PFS in the general population (<i>p</i> = 0.0233) and in the non-resected NSCLC subgroup (<i>p</i> = 0.0233). In the resected NSCLC subgroup, rs11568820 was associated with OS (<i>p</i> = 0.0129) and rs7041 with PFS (<i>p</i> = 0.0447). In the non-resected NSCLC subgroup, rs6068816 was associated with PFS (<i>p</i> = 0.0048) and OS (<i>p</i> = 0.0089) and rs731236 and rs7975232 were associated with OS (<i>p</i> = 0.0005) and PFS (<i>p</i> = 0.0002), respectively. The other polymorphisms showed no effect on the results. The rs4646536, rs6068816, rs7041, rs11568820, rs731236, and rs7975232 polymorphisms are associated with survival in NSCLC and may have a substantial role as prognostic markers of the disease.
first_indexed 2024-03-10T05:12:11Z
format Article
id doaj.art-bf9fa9de08f24e2aa9dd67acdbddf3e6
institution Directory Open Access Journal
issn 2072-6643
language English
last_indexed 2024-03-10T05:12:11Z
publishDate 2021-10-01
publisher MDPI AG
record_format Article
series Nutrients
spelling doaj.art-bf9fa9de08f24e2aa9dd67acdbddf3e62023-11-23T00:45:51ZengMDPI AGNutrients2072-66432021-10-011311378310.3390/nu13113783Impact of Genetic Polymorphisms on the Metabolic Pathway of Vitamin D and Survival in Non-Small Cell Lung CancerLaura Elena Pineda Lancheros0Cristina Pérez Ramírez1Almudena Sánchez Martín2José María Gálvez Navas3Fernando Martínez Martínez4María del Carmen Ramírez Tortosa5Alberto Jiménez Morales6Pharmacy Service, Pharmacogenetics Unit, University Hospital Virgen de las Nieves, 18014 Granada, SpainPharmacy Service, Pharmacogenetics Unit, University Hospital Virgen de las Nieves, 18014 Granada, SpainPharmacy Service, Pharmacogenetics Unit, University Hospital Virgen de las Nieves, 18014 Granada, SpainPharmacy Service, Pharmacogenetics Unit, University Hospital Virgen de las Nieves, 18014 Granada, SpainDepartment of Pharmacy and Pharmaceutical Technology, Social and Legal Assistance Pharmacy Section, Faculty of Pharmacy, University of Granada, 18071 Granada, SpainCenter of Biomedical Research, Department of Biochemistry and Molecular Biology II, Institute of Nutrition and Food Technology “José Mataix”, University of Granada, Avda. del Conocimiento s/n., 18016 Granada, SpainPharmacy Service, Pharmacogenetics Unit, University Hospital Virgen de las Nieves, 18014 Granada, SpainVitamin D has been associated with risk, development, and progression of cancer. However, the genes involved in its metabolism are highly polymorphic, compromising its activity. The aim of this study is to evaluate the association between the gene polymorphisms involved in the metabolic pathway of vitamin D and survival in patients with non-small-cell lung cancer (NSCLC). The study was designed as an observational cohort which included 194 Caucasians patients from southern Spain with NSCLC. Real-time polymerase chain reaction was used to analyze the following polymorphisms: <i>CYP27B1</i> rs4646536, rs3782130, and rs10877012; <i>CYP24A1</i> rs6068816 and rs4809957; <i>GC</i> rs7041; <i>CYP2R1</i> rs10741657; <i>VDR</i> rs1544410 (BsmI), rs11568820 (Cdx-2), rs2228570 (FokI), rs7975232 (ApaI), and rs731236 (TaqI). Progression-free survival (PFS) and overall survival were assessed. Cox regression showed that rs4646536 was associated with PFS in the general population (<i>p</i> = 0.0233) and in the non-resected NSCLC subgroup (<i>p</i> = 0.0233). In the resected NSCLC subgroup, rs11568820 was associated with OS (<i>p</i> = 0.0129) and rs7041 with PFS (<i>p</i> = 0.0447). In the non-resected NSCLC subgroup, rs6068816 was associated with PFS (<i>p</i> = 0.0048) and OS (<i>p</i> = 0.0089) and rs731236 and rs7975232 were associated with OS (<i>p</i> = 0.0005) and PFS (<i>p</i> = 0.0002), respectively. The other polymorphisms showed no effect on the results. The rs4646536, rs6068816, rs7041, rs11568820, rs731236, and rs7975232 polymorphisms are associated with survival in NSCLC and may have a substantial role as prognostic markers of the disease.https://www.mdpi.com/2072-6643/13/11/3783vitamin D metabolismsurvivalnon-small-cell lung cancersingle nucleotide polymorphisms<i>CYP27B1</i><i>CYP24A1</i>
spellingShingle Laura Elena Pineda Lancheros
Cristina Pérez Ramírez
Almudena Sánchez Martín
José María Gálvez Navas
Fernando Martínez Martínez
María del Carmen Ramírez Tortosa
Alberto Jiménez Morales
Impact of Genetic Polymorphisms on the Metabolic Pathway of Vitamin D and Survival in Non-Small Cell Lung Cancer
Nutrients
vitamin D metabolism
survival
non-small-cell lung cancer
single nucleotide polymorphisms
<i>CYP27B1</i>
<i>CYP24A1</i>
title Impact of Genetic Polymorphisms on the Metabolic Pathway of Vitamin D and Survival in Non-Small Cell Lung Cancer
title_full Impact of Genetic Polymorphisms on the Metabolic Pathway of Vitamin D and Survival in Non-Small Cell Lung Cancer
title_fullStr Impact of Genetic Polymorphisms on the Metabolic Pathway of Vitamin D and Survival in Non-Small Cell Lung Cancer
title_full_unstemmed Impact of Genetic Polymorphisms on the Metabolic Pathway of Vitamin D and Survival in Non-Small Cell Lung Cancer
title_short Impact of Genetic Polymorphisms on the Metabolic Pathway of Vitamin D and Survival in Non-Small Cell Lung Cancer
title_sort impact of genetic polymorphisms on the metabolic pathway of vitamin d and survival in non small cell lung cancer
topic vitamin D metabolism
survival
non-small-cell lung cancer
single nucleotide polymorphisms
<i>CYP27B1</i>
<i>CYP24A1</i>
url https://www.mdpi.com/2072-6643/13/11/3783
work_keys_str_mv AT lauraelenapinedalancheros impactofgeneticpolymorphismsonthemetabolicpathwayofvitamindandsurvivalinnonsmallcelllungcancer
AT cristinaperezramirez impactofgeneticpolymorphismsonthemetabolicpathwayofvitamindandsurvivalinnonsmallcelllungcancer
AT almudenasanchezmartin impactofgeneticpolymorphismsonthemetabolicpathwayofvitamindandsurvivalinnonsmallcelllungcancer
AT josemariagalveznavas impactofgeneticpolymorphismsonthemetabolicpathwayofvitamindandsurvivalinnonsmallcelllungcancer
AT fernandomartinezmartinez impactofgeneticpolymorphismsonthemetabolicpathwayofvitamindandsurvivalinnonsmallcelllungcancer
AT mariadelcarmenramireztortosa impactofgeneticpolymorphismsonthemetabolicpathwayofvitamindandsurvivalinnonsmallcelllungcancer
AT albertojimenezmorales impactofgeneticpolymorphismsonthemetabolicpathwayofvitamindandsurvivalinnonsmallcelllungcancer